StockpollyBeta
Get App
Popularity #2,310
FTH · NASDAQ · Biotechnology

Faeth Therapeutics (FTH)

Develops PIKTOR, an oral cancer regimen designed to block multiple PAM-pathway nodes.

$31.84
vs last close−1.56 (−4.67%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue0000000−5000
Cost of revenue0000000−501330
Gross profit000000000−1330
8988775553818
Research & development455544332189
443334323209
Selling & marketing00000000000
General & administrative040004323209
Operating income−8−9−8−8−7−7−5−5−5−171−18
11110000002
Interest income11111000002
Interest expense00000000000
Other non-operating income−1−1−1−1000000−2
Income before tax−7−8−7−7−8−7−5−5−5−170−16
Net income from continuing operations−7−8−7−7−8−7−5−5−5−170−16
Net income−7−8−7−7−8−7−5−5−5−170−16
EPS, basic−$5.92−$6.38−$5.69−$5.77−$6.18−$5.45−$3.91−$3.62−$3.74−$131.45−$2.84
EPS, diluted−$5.92−$6.38−$5.69−$5.77−$6.18−$5.45−$3.91−$3.62−$3.74−$131.45−$2.84
Weighted average shares, basic11111111116
Weighted average shares, diluted11111111116
EBITDA−7−8−7−7−8−7−5−5−5−170−16
Depreciation & amortization00000000000
EBIT−7−8−7−7−8−7−5−5−5−170−16